Global Benign Prostatic Hypertrophy Implant Devices Market Growth 2021-2027
According to this latest study, the 2021 growth of Benign Prostatic Hypertrophy Implant Devices will have significant change from previous year. By the most conservative estimates of global Benign Prostatic Hypertrophy Implant Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Benign Prostatic Hypertrophy Implant Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2027.
This report presents a comprehensive overview, market shares, and growth opportunities of Benign Prostatic Hypertrophy Implant Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2027 in section 11.7.
Temporary
Long-term
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2027 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Olympus Medical
Butterfly Medical
SRS Medical
Teleflex Interventional Urology
Urotronic
Zenflow
ProArc Medical
Medeon Biodesign
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Benign Prostatic Hypertrophy Implant Devices Consumption 2016-2026
2.1.2 Benign Prostatic Hypertrophy Implant Devices Consumption CAGR by Region
2.2 Benign Prostatic Hypertrophy Implant Devices Segment by Type
2.2.1 Temporary
2.2.2 Long-term
2.3 Benign Prostatic Hypertrophy Implant Devices Sales by Type
2.3.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2016-2021)
2.3.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue and Market Share by Type (2016-2021)
2.3.3 Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Type (2016-2021)
2.4 Benign Prostatic Hypertrophy Implant Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Benign Prostatic Hypertrophy Implant Devices Sales by Application
2.5.1 Global Benign Prostatic Hypertrophy Implant Devices Sale Market Share by Application (2016-2021)
2.5.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue and Market Share by Application (2016-2021)
2.5.3 Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Application (2016-2021)
3 Global Benign Prostatic Hypertrophy Implant Devices by Company
3.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Company
3.1.1 Global Benign Prostatic Hypertrophy Implant Devices Sales by Company (2019-2021)
3.1.2 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Company (2019-2021)
3.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Company
3.2.1 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Company (2019-2021)
3.2.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Company (2019-2021)
3.3 Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Company
3.4 Global Manufacturers Benign Prostatic Hypertrophy Implant Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Benign Prostatic Hypertrophy Implant Devices Product Location Distribution
3.4.2 Players Benign Prostatic Hypertrophy Implant Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Benign Prostatic Hypertrophy Implant Devices by Region
4.1 Global Benign Prostatic Hypertrophy Implant Devices by Region
4.1.1 Global Benign Prostatic Hypertrophy Implant Devices Sales by Region
4.1.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue by Region
4.2 Americas Benign Prostatic Hypertrophy Implant Devices Sales Growth
4.3 APAC Benign Prostatic Hypertrophy Implant Devices Sales Growth
4.4 Europe Benign Prostatic Hypertrophy Implant Devices Sales Growth
4.5 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Growth
5 Americas
5.1 Americas Benign Prostatic Hypertrophy Implant Devices Sales by Country
5.1.1 Americas Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021)
5.1.2 Americas Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021)
5.2 Americas Benign Prostatic Hypertrophy Implant Devices Sales by Type
5.3 Americas Benign Prostatic Hypertrophy Implant Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Benign Prostatic Hypertrophy Implant Devices Sales by Region
6.1.1 APAC Benign Prostatic Hypertrophy Implant Devices Sales by Region (2016-2021)
6.1.2 APAC Benign Prostatic Hypertrophy Implant Devices Revenue by Region (2016-2021)
6.2 APAC Benign Prostatic Hypertrophy Implant Devices Sales by Type
6.3 APAC Benign Prostatic Hypertrophy Implant Devices Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Benign Prostatic Hypertrophy Implant Devices by Country
7.1.1 Europe Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021)
7.1.2 Europe Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021)
7.2 Europe Benign Prostatic Hypertrophy Implant Devices Sales by Type
7.3 Europe Benign Prostatic Hypertrophy Implant Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices by Country
8.1.1 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021)
8.1.2 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021)
8.2 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Type
8.3 Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Benign Prostatic Hypertrophy Implant Devices Distributors
10.3 Benign Prostatic Hypertrophy Implant Devices Customer
11 Global Benign Prostatic Hypertrophy Implant Devices Market Forecast
11.1 Global Benign Prostatic Hypertrophy Implant Devices Forecast by Region
11.1.1 Global Benign Prostatic Hypertrophy Implant Devices Forecast by Regions (2021-2026)
11.2.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Benign Prostatic Hypertrophy Implant Devices Forecast by Type
11.7 Global Benign Prostatic Hypertrophy Implant Devices Forecast by Application
12 Key Players Analysis
12.1 Olympus Medical
12.1.1 Olympus Medical Company Information
12.1.2 Olympus Medical Benign Prostatic Hypertrophy Implant Devices Product Offered
12.1.3 Olympus Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Olympus Medical Main Business Overview
12.1.5 Olympus Medical Latest Developments
12.2 Butterfly Medical
12.2.1 Butterfly Medical Company Information
12.2.2 Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Product Offered
12.2.3 Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Butterfly Medical Main Business Overview
12.2.5 Butterfly Medical Latest Developments
12.3 SRS Medical
12.3.1 SRS Medical Company Information
12.3.2 SRS Medical Benign Prostatic Hypertrophy Implant Devices Product Offered
12.3.3 SRS Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 SRS Medical Main Business Overview
12.3.5 SRS Medical Latest Developments
12.4 Teleflex Interventional Urology
12.4.1 Teleflex Interventional Urology Company Information
12.4.2 Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Product Offered
12.4.3 Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Teleflex Interventional Urology Main Business Overview
12.4.5 Teleflex Interventional Urology Latest Developments
12.5 Urotronic
12.5.1 Urotronic Company Information
12.5.2 Urotronic Benign Prostatic Hypertrophy Implant Devices Product Offered
12.5.3 Urotronic Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Urotronic Main Business Overview
12.5.5 Urotronic Latest Developments
12.6 Zenflow
12.6.1 Zenflow Company Information
12.6.2 Zenflow Benign Prostatic Hypertrophy Implant Devices Product Offered
12.6.3 Zenflow Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Zenflow Main Business Overview
12.6.5 Zenflow Latest Developments
12.7 ProArc Medical
12.7.1 ProArc Medical Company Information
12.7.2 ProArc Medical Benign Prostatic Hypertrophy Implant Devices Product Offered
12.7.3 ProArc Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 ProArc Medical Main Business Overview
12.7.5 ProArc Medical Latest Developments
12.8 Medeon Biodesign
12.8.1 Medeon Biodesign Company Information
12.8.2 Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Product Offered
12.8.3 Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Medeon Biodesign Main Business Overview
12.8.5 Medeon Biodesign Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Benign Prostatic Hypertrophy Implant Devices Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Temporary
Table 3. Major Players of Long-term
Table 4. Global Benign Prostatic Hypertrophy Implant Devices Sales by Type (2016-2021) & (Units)
Table 5. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2016-2021)
Table 6. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Type (2016-2021) & ($ million)
Table 7. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Type (2016-2021)
Table 8. Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Type (2016-2021)
Table 9. Global Benign Prostatic Hypertrophy Implant Devices Sales by Application (2016-2021) & (Units)
Table 10. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2016-2021)
Table 11. Global Benign Prostatic Hypertrophy Implant Devices Value by Application (2016-2021)
Table 12. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Application (2016-2021)
Table 13. Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Application (2016-2021)
Table 14. Global Benign Prostatic Hypertrophy Implant Devices Sales by Company (2019-2021) & (Units)
Table 15. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Company (2019-2021)
Table 16. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Company (2019-2021)
Table 18. Global Benign Prostatic Hypertrophy Implant Devices Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Benign Prostatic Hypertrophy Implant Devices Producing Area Distribution and Sales Area
Table 20. Players Benign Prostatic Hypertrophy Implant Devices Products Offered
Table 21. Benign Prostatic Hypertrophy Implant Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Benign Prostatic Hypertrophy Implant Devices Sales by Region (2016-2021) (Units)
Table 25. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region (2016-2021)
Table 26. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Region (2016-2021)
Table 28. Americas Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021) & (Units)
Table 29. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2016-2021)
Table 30. Americas Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2016-2021)
Table 32. Americas Benign Prostatic Hypertrophy Implant Devices Sales by Type (2016-2021) & (Units)
Table 33. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2016-2021)
Table 34. Americas Benign Prostatic Hypertrophy Implant Devices Sales by Application (2016-2021) & (Units)
Table 35. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2016-2021)
Table 36. APAC Benign Prostatic Hypertrophy Implant Devices Sales by Region (2016-2021) & (Units)
Table 37. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region (2016-2021)
Table 38. APAC Benign Prostatic Hypertrophy Implant Devices Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Region (2016-2021)
Table 40. APAC Benign Prostatic Hypertrophy Implant Devices Sales by Type (2016-2021) & (Units)
Table 41. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2016-2021)
Table 42. APAC Benign Prostatic Hypertrophy Implant Devices Sales by Application (2016-2021) & (Units)
Table 43. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2016-2021)
Table 44. Europe Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021) & (Units)
Table 45. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2016-2021)
Table 46. Europe Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2016-2021)
Table 48. Europe Benign Prostatic Hypertrophy Implant Devices Sales by Type (2016-2021) & (Units)
Table 49. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2016-2021)
Table 50. Europe Benign Prostatic Hypertrophy Implant Devices Sales by Application (2016-2021) & (Units)
Table 51. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021) & (Units)
Table 53. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Type (2016-2021) & (Units)
Table 57. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales by Application (2016-2021) & (Units)
Table 59. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Benign Prostatic Hypertrophy Implant Devices
Table 61. Key Application and Potential Industries of Benign Prostatic Hypertrophy Implant Devices
Table 62. Key Challenges of Benign Prostatic Hypertrophy Implant Devices
Table 63. Key Trends of Benign Prostatic Hypertrophy Implant Devices
Table 64. Benign Prostatic Hypertrophy Implant Devices Distributors List
Table 65. Benign Prostatic Hypertrophy Implant Devices Customer List
Table 66. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Region (2021-2026) & (Units)
Table 67. Global Benign Prostatic Hypertrophy Implant Devices Consumption Market Forecast by Region
Table 68. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Country (2021-2026) & (Units)
Table 71. Americas Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Region (2021-2026) & (Units)
Table 73. APAC Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Country (2021-2026) & (Units)
Table 75. Europe Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Country (2021-2026) & (Units)
Table 77. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Type (2021-2026) & (Units)
Table 79. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Application (2021-2026) & (Units)
Table 83. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Application (2021-2026)
Table 86. Olympus Medical Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors
Table 87. Olympus Medical Benign Prostatic Hypertrophy Implant Devices Product Offered
Table 88. Olympus Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Olympus Medical Main Business
Table 90. Olympus Medical Latest Developments
Table 91. Butterfly Medical Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors
Table 92. Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Product Offered
Table 93. Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Butterfly Medical Main Business
Table 95. Butterfly Medical Latest Developments
Table 96. SRS Medical Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. SRS Medical Benign Prostatic Hypertrophy Implant Devices Product Offered
Table 98. SRS Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. SRS Medical Main Business
Table 100. SRS Medical Latest Developments
Table 101. Teleflex Interventional Urology Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Product Offered
Table 103. Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Teleflex Interventional Urology Main Business
Table 105. Teleflex Interventional Urology Latest Developments
Table 106. Urotronic Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. Urotronic Benign Prostatic Hypertrophy Implant Devices Product Offered
Table 108. Urotronic Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Urotronic Main Business
Table 110. Urotronic Latest Developments
Table 111. Zenflow Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. Zenflow Benign Prostatic Hypertrophy Implant Devices Product Offered
Table 113. Zenflow Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Zenflow Main Business
Table 115. Zenflow Latest Developments
Table 116. ProArc Medical Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. ProArc Medical Benign Prostatic Hypertrophy Implant Devices Product Offered
Table 118. ProArc Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. ProArc Medical Main Business
Table 120. ProArc Medical Latest Developments
Table 121. Medeon Biodesign Basic Information, Benign Prostatic Hypertrophy Implant Devices Manufacturing Base, Sales Area and Its Competitors
Table 122. Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Product Offered
Table 123. Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Medeon Biodesign Main Business
Table 125. Medeon Biodesign Latest Developments
List of Figures
Figure 1. Picture of Benign Prostatic Hypertrophy Implant Devices
Figure 2. Benign Prostatic Hypertrophy Implant Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Benign Prostatic Hypertrophy Implant Devices Sales Growth Rate 2016-2026 (Units)
Figure 7. Global Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Benign Prostatic Hypertrophy Implant Devices Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Temporary
Figure 10. Product Picture of Long-term
Figure 11. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type in 2020
Figure 12. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Type (2016-2021)
Figure 13. Benign Prostatic Hypertrophy Implant Devices Consumed in Hospital
Figure 14. Global Benign Prostatic Hypertrophy Implant Devices Market: Hospital (2016-2021) & (Units)
Figure 15. Benign Prostatic Hypertrophy Implant Devices Consumed in Clinic
Figure 16. Global Benign Prostatic Hypertrophy Implant Devices Market: Clinic (2016-2021) & (Units)
Figure 17. Benign Prostatic Hypertrophy Implant Devices Consumed in Other
Figure 18. Global Benign Prostatic Hypertrophy Implant Devices Market: Other (2016-2021) & (Units)
Figure 19. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2016-2021)
Figure 20. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Application in 2020
Figure 21. Benign Prostatic Hypertrophy Implant Devices Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Company in 2020
Figure 23. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Regions (2016-2021)
Figure 24. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Region in 2020
Figure 25. Americas Benign Prostatic Hypertrophy Implant Devices Sales 2016-2021 (Units)
Figure 26. Americas Benign Prostatic Hypertrophy Implant Devices Revenue 2016-2021 ($ Millions)
Figure 27. APAC Benign Prostatic Hypertrophy Implant Devices Sales 2016-2021 (Units)
Figure 28. APAC Benign Prostatic Hypertrophy Implant Devices Revenue 2016-2021 ($ Millions)
Figure 29. Europe Benign Prostatic Hypertrophy Implant Devices Sales 2016-2021 (Units)
Figure 30. Europe Benign Prostatic Hypertrophy Implant Devices Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales 2016-2021 (Units)
Figure 32. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue 2016-2021 ($ Millions)
Figure 33. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country in 2020
Figure 34. Americas Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country in 2020
Figure 35. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type in 2020
Figure 36. Americas Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application in 2020
Figure 37. United States Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region in 2020
Figure 42. APAC Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Regions in 2020
Figure 43. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type in 2020
Figure 44. APAC Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application in 2020
Figure 45. China Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country in 2020
Figure 52. Europe Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country in 2020
Figure 53. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type in 2020
Figure 54. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application in 2020
Figure 55. Germany Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application in 2020
Figure 64. Egypt Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Benign Prostatic Hypertrophy Implant Devices Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
